Adaptive COVID-19 Treatment Trial 4 (ACTT-4)
Clinical trial NCT04640168 · COMPLETED
Trial details
- NCT number
- NCT04640168
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-02
- Primary completion
- 2021-05-18
- Enrollment
- 1010
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.